Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type IV Collagen of Basal Lamina01:05

Type IV Collagen of Basal Lamina

Type IV collagen is a 400 nm long, network-forming collagen that acts as a barrier between the epithelial and endothelial cells. Type IV collagen  forms the backbone of the basement membrane by scaffolding with laminin, entactin, proteoglycans, and fibronectin. Apart from rendering structural support to the basement membrane, it also helps entail signaling potentials necessary for both pathological and physiological functions.
A type IV collagen molecule has six alpha chains which can exist in...
Fibril-associated Collagen01:11

Fibril-associated Collagen

Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Minimal change disease onset observed after bevacizumab administration.

Clinical kidney journal·2016
Same author

Hypertension-attributed nephropathy: what's in a name?

Nature reviews. Nephrology·2015
Same author

Association of histologic variants in FSGS clinical trial with presenting features and outcomes.

Clinical journal of the American Society of Nephrology : CJASN·2012
Same author

A position paper on standardizing the nonneoplastic kidney biopsy report.

Human pathology·2012
Same author

A position paper on standardizing the nonneoplastic kidney biopsy report.

Clinical journal of the American Society of Nephrology : CJASN·2012
Same author

Metabolic and morphometric profile of muscle fibers in chronic hemodialysis patients.

Journal of applied physiology (Bethesda, Md. : 1985)·2011
Same journal

The Physician Leader: Teaching Leadership in Medicine.

Advances in chronic kidney disease·2022
Same journal

Postgraduate Education and Training for the Nephrology Physician Assistants and Nurse Practitioners.

Advances in chronic kidney disease·2022
Same journal

Evaluation Evolution: Designing Optimal Evaluations to Enhance Learning in Nephrology Fellowship.

Advances in chronic kidney disease·2022
Same journal

Kidney Pathology Education for Nephrology Fellows: Past, Present, and Future.

Advances in chronic kidney disease·2022
Same journal

Clinician Educator Pathway for Nephrology Fellows: The University of North Carolina Experience.

Advances in chronic kidney disease·2022
Same journal

Current Trends and Challenges in Nephrology Fellowship Training: Expansion of Education in Home Dialysis, Palliative Care, and Point-of-Care Ultrasound.

Advances in chronic kidney disease·2022
See all related articles

Related Experiment Video

Updated: May 23, 2026

Generation of 3-D Collagen-based Hydrogels to Analyze Axonal Growth and Behavior During Nervous System Development
09:10

Generation of 3-D Collagen-based Hydrogels to Analyze Axonal Growth and Behavior During Nervous System Development

Published on: June 25, 2019

Collagen Type III Glomerulopathies.

Arthur H Cohen1

  • 1Department of Pathology, Cedars-Sinai Medical Center, Los Angeles, California 90048, USA. cohena@cshs.org

Advances in Chronic Kidney Disease
|March 28, 2012
PubMed
Summary
This summary is machine-generated.

Two rare kidney diseases, collagenofibrotic glomerulopathy and nail-patella syndrome, involve abnormal collagen type III accumulation in glomeruli. Diagnosis relies on kidney biopsy, revealing distinct collagen distributions and underlying genetic causes.

More Related Videos

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

Related Experiment Videos

Last Updated: May 23, 2026

Generation of 3-D Collagen-based Hydrogels to Analyze Axonal Growth and Behavior During Nervous System Development
09:10

Generation of 3-D Collagen-based Hydrogels to Analyze Axonal Growth and Behavior During Nervous System Development

Published on: June 25, 2019

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

Area of Science:

  • Nephrology
  • Genetics
  • Pathology

Background:

  • Two rare glomerular disorders, collagenofibrotic glomerulopathy and nail-patella syndrome, are characterized by pathological collagen type III accumulation.
  • Despite morphological similarities, these conditions lack a direct genetic or pathogenic link.

Purpose of the Study:

  • To discuss and differentiate collagenofibrotic glomerulopathy and nail-patella syndrome.
  • To highlight the distinct pathological features and genetic underpinnings of each disease.

Main Methods:

  • Review of clinical presentations and diagnostic findings for both disorders.
  • Analysis of kidney biopsy results showing collagen type III deposition patterns.
  • Examination of genetic mutations associated with nail-patella syndrome.

Main Results:

  • Collagenofibrotic glomerulopathy presents sporadically or with autosomal recessive inheritance, typically causing proteinuria and progressing to end-stage renal disease (ESRD).
  • Kidney biopsy reveals type III collagen in subendothelial and mesangial areas.
  • Nail-patella syndrome, caused by LMX1B mutations, presents with proteinuria and distinct type III collagen deposition within glomerular basement membranes.

Conclusions:

  • Collagenofibrotic glomerulopathy and nail-patella syndrome are distinct entities despite shared collagen type III abnormalities.
  • Accurate diagnosis requires careful evaluation of clinical presentation, biopsy findings, and genetic analysis.